title: Transient fasting enhances replication of oncolytic herpes simplex virus in glioblastoma.
abstract: Short-term nutritional restriction (fasting) has been shown to enhance the efficacy of chemotherapy by sensitizing cancer cells and protecting normal cells in a variety of cancer models, including glioblastoma (GBM). Cancer cells, unlike normal cells, respond to fasting by promoting oncogenic signaling and protein synthesis. We hypothesized that fasting would increase the replication of oncolytic herpes simplex virus (oHSV) in GBM. Patient-derived GBM cell lines were fasted by growth in glucose and fetal calf serum restricted culture medium. "Transient fasting", 24-hour fasting followed by 24-hour recovery in complete medium, increased late virus gene expression and G47Δ yields about 2-fold in GBM cells, but not in human astrocytes, and enhanced G47Δ killing of GBM cells. Mechanistically, "transient fasting" suppressed phosphorylation of the subunit of eukaryotic initiation factor 2α (eIF2α) and c-Jun N-terminal kinases (JNK) in GBM cells, but not in astrocytes. Pharmacological inhibition of JNK also increased G47Δ yield. In vivo, transient fasting (48-hour food restriction and 24-hour recovery) doubled luciferase activity after intratumoral G47Δ-US11fluc injection into orthotopic GBM xenografts. Thus, "transient fasting" increases G47Δ replication and oncolytic activity in human GBM cells. These results suggest that "transient fasting" may be effectively combined to enhance oncolytic HSV therapy of GBM.
authors.affiliation: Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical SchoolBoston, MA 02114, USA; Present Address: Department of Otolaryngology, Head & Neck Surgery, Nagoya City University Graduate School of Medical Sciences and Medical SchoolNagoya, Japan.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Esaki
authors.affiliation: Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA 02114, USA.
authors.forename: Samuel D
authors.initials: SD
authors.lastname: Rabkin
authors.affiliation: Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA 02114, USA.
authors.forename: Robert L
authors.initials: RL
authors.lastname: Martuza
authors.affiliation: Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School Boston, MA 02114, USA.
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Wakimoto
keywords: JNK; Oncolytic HSV; eIF2α; fasting; glioblastoma; mTOR